Page last updated: 2024-10-25

cimetidine and Pituitary Diseases

cimetidine has been researched along with Pituitary Diseases in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Pituitary Diseases: Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García Centenera, JA1
Requejo, F1
Alba, JP1
Herrán, M1
Lucero, JL1
Vilchez, JM1
Hervás, F1

Trials

1 trial available for cimetidine and Pituitary Diseases

ArticleYear
[H2-receptors and prolactin secretion. Effects of acute and chronic administration of cimetidine on subjects with normal and high levels of prolactin (author's transl)].
    Medicina clinica, 1980, Jan-10, Volume: 74, Issue:1

    Topics: Adult; Cimetidine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Guanidines; Humans; I

1980